Exelixis
EXEL
#1675
Rank
HK$101.29 B
Marketcap
HK$402.99
Share price
-1.95%
Change (1 day)
24.13%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company